Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DiaSorin Marks Significant Growth in Molecular Extraction Kit Sales

Published: Friday, February 14, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status.

The Milan-based Life Science Division of Voden Medical Instruments S.p.A. has been awarded DiaSorin Platinum Distributor status in recognition of their outstanding contribution to sales of the DiaSorin Arrow instrument and molecular extraction kits throughout Italy.

Meeting the specific needs of HLA (human leukocyte antigen) testing laboratories, assessing tissue compatibility in organ transplant patients, the Arrow Blood DNA extraction kit has shown particular growth and completes the Voden product offering for this important molecular investigation.

“We value the role of our Distributors in promoting and selling DiaSorin products at a local level,” comments Paul Eros, Global Vice President Molecular, DiaSorin. "We have seen extraordinary growth in the sales of Arrow extraction kits in Italy over the last year and we are delighted to recognize the efforts of Voden Medical Instruments in maximizing opportunities for Arrow products in Italy’s Life Science market.”

“The Arrow extraction kits have given us a good entry into the HLA laboratory market and have presented opportunities to promote and sell other products in our portfolio,” comments Andrea Dell’ Acqua, Division Manager, Voden. “The ability to automate routine tasks in the laboratory is what our customers want and the Arrow range allows us to meet this need.”

“The Arrow extraction kits not only meet the need for standardization in the laboratory but they also offer flexibility,” adds Claudio Mazzei, Sales and Applications Manager, Voden, “The Arrow instrument allows between one and 12 samples to be processed at a time, with no waste of reagents for smaller batches. Other kits don’t have this flexibility. The instrument is fully automated and very easy to use. This, combined with the flexibility to process individual samples, is ideal if an urgent transplant sample comes in during the night and needs to be analyzed quickly.”

“The small footprint of the Arrow instrument is ideal,” continues Claudio Mazzei. “Both for our customers, who may have limited space or who might want to move the instrument from one lab to another, and for our sales team who can easily transport the machine for demonstration purposes. The support that DiaSorin provides is exemplary, giving us confidence that we can respond to our customers very quickly. In particular the training facilities in Dublin are excellent and the training very thorough and professional.”

“The DiaSorin Arrow instrument and extraction assays have helped to grow our business in the HLA laboratory market and have enabled us to offer Life Science customers the complete solution,” concludes Andrea Dell ‘Acqua. “We are confident that, as a major global diagnostics company, DiaSorin will continue to develop the product range, which will help us to have a greater presence in the Life Science market. For example, we are eagerly awaiting the new kit for the extraction of RNA from blood that DiaSorin is currently developing, which will help us to enhance our offering for other applications and to further increase our potential market.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!